APUS Earnings Date: Nov 11, 2026 (Estimated) — Apimeds Pharmaceuticals US, Inc
AMEX · Healthcare · Drug Manufacturers - Specialty & Generic
Updated
When is APUS's next earnings date?
Apimeds Pharmaceuticals US, Inc (APUS) is expected to report Q3 2026 earnings on Wednesday, November 11, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company.
How did APUS do in its last earnings report?
In its most recent report on Aug 14, 2026 (Q2 2026), Apimeds Pharmaceuticals US, Inc posted EPS of -$11.77. Revenue was $0. The stock's 1-day post-earnings move was -5.9%.
How much does APUS stock move after earnings?
Over the last 5 reports the stock moved an average of 3.0% (up or down) in the day after earnings.
About Apimeds Pharmaceuticals US, Inc
Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-14 | Q2 2026 | — | -11.77 | — | $0 | — | -5.93% | +6.37% | -63.96% |
| 2026-05-26 | Q1 2026 | — | -2.26 | — | $0 | — | +0.00% | -7.04% | -39.58% |
| 2026-05-04 | Q4 2025 | — | -0.80 | — | $0 | — | +0.00% | -19.47% | -29.79% |
| 2025-11-12 | Q3 2025 | — | -0.14 | — | $0 | — | +4.10% | +13.06% | -20.15% |
| 2025-08-19 | Q2 2025 | — | -0.26 | — | $0 | — | -4.74% | -1.05% | -3.68% |
Showing last 5 quarters.